.5 minute read
The Federal Trade Commission (FTC) will investigate the six largest pharmacy benefit managers (PBMs) in the U.S. PBMs are the middlemen who negotiate with drugmakers for rebates and lower fees and reimburse pharmacies for prescriptions they distribute. PBMs influence which medicine most Americans receive, which pharmacies they can use, and how much they pay.
The PBMs will be asked to provide information and records about their business practices. The inquiry should provide clarity on how PBMs impact pharmacies, payers, doctors, and patients and potentially direct any needed reform to help address the rising prescription drug prices.
Download the bulletin for more details.
National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.
